Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease

Risultato della ricerca: Contributo in rivistaArticolo in rivista

9 Citazioni (Scopus)

Abstract

Ocular chronic GVHD is efficaciously treated with autologous platelet-derived eye drops. We investigated the cytokine content of eye drops produced using a non-gelified lysate obtained from autologous platelet-rich plasma in six patients with ocular GVHD. In both the responding (n = 4) and the resistant (n = 2) patients, the eye drops were significantly enriched with various growth factors, in amounts proportional with the platelet counts. In contrast, chemokine ligand and interleukin levels were similar to those of plasma. The non-responding patients showed the highest levels of chemokine (C-X-C motif) ligand (CXCL)10. These findings provide possible explanations for beneficial or detrimental effects of eye drops.
Lingua originaleEnglish
pagine (da-a)N/A-N/A
RivistaVox Sanguinis
Volume2015
DOI
Stato di pubblicazionePubblicato - 2015

Keywords

  • GVHD
  • autologous platelet lysates
  • chemokines
  • dry eye syndrome
  • growth factors

Fingerprint Entra nei temi di ricerca di 'Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease'. Insieme formano una fingerprint unica.

Cita questo